170 related articles for article (PubMed ID: 31630477)
21. Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice.
Fernández-Ruiz M; Bodro M; Gutiérrez Martín I; Rodriguez-Álvarez R; Ruiz-Ruigómez M; Sabé N; López-Viñau T; Valerio M; Illaro A; Fortún J; Salto-Alejandre S; Cordero E; Fariñas MDC; Muñoz P; Vidal E; Carratalà J; Goikoetxea J; Ramos-Martínez A; Moreno A; Aguado JM;
Transplantation; 2023 Mar; 107(3):762-773. PubMed ID: 36367924
[TBL] [Abstract][Full Text] [Related]
22. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
[TBL] [Abstract][Full Text] [Related]
23. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
Patterson JE; Peters J; Calhoon JH; Levine S; Anzueto A; Al-Abdely H; Sanchez R; Patterson TF; Rech M; Jorgensen JH; Rinaldi MG; Sako E; Johnson S; Speeg V; Halff GA; Trinkle JK
Transpl Infect Dis; 2000 Mar; 2(1):22-8. PubMed ID: 11429006
[TBL] [Abstract][Full Text] [Related]
24. Mold Infections in Solid Organ Transplant Recipients.
Lemonovich TL
Infect Dis Clin North Am; 2018 Sep; 32(3):687-701. PubMed ID: 30146030
[TBL] [Abstract][Full Text] [Related]
25. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
26. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
Gioia F; Filigheddu E; Corbella L; Fernández-Ruiz M; López-Medrano F; Pérez-Ayala A; Aguado JM; Fariñas MC; Arnaiz F; Calvo J; Cifrian JM; Gonzalez-Rico C; Vidal E; Torre-Cisneros J; Ras MM; Pérez S; Sabe N; López-Soria LM; Rodríguez-Alvarez RJ; Montejo JM; Valerio M; Machado M; Muñoz P; Linares L; Bodro M; Moreno A; Fernández-Cruz A; Cantón R; Moreno S; Martin-Davila P; Fortún J
Mycoses; 2021 Nov; 64(11):1334-1345. PubMed ID: 33934405
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of invasive respiratory disease caused by emerging non-Aspergillus molds in lung transplant recipients.
Peghin M; Monforte V; Martin-Gomez MT; Ruiz-Camps I; Berastegui C; Saez B; Riera J; Solé J; Gavaldá J; Roman A
Transpl Infect Dis; 2016 Feb; 18(1):70-8. PubMed ID: 26678668
[TBL] [Abstract][Full Text] [Related]
28. Sepsis outcomes in solid organ transplant recipients.
Gotur DB; Masud FN; Ezeana CF; Nisar T; Paranilam J; Chen S; Puppala M; Wong STC; Zimmerman JL
Transpl Infect Dis; 2020 Feb; 22(1):e13214. PubMed ID: 31755202
[TBL] [Abstract][Full Text] [Related]
29. Use of echinocandin prophylaxis in solid organ transplantation.
Giannella M; Husain S; Saliba F; Viale P
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i51-i59. PubMed ID: 29304212
[TBL] [Abstract][Full Text] [Related]
30. Culture-Positive Pulmonary Aspergillosis Infection: Clinical and Laboratory Features of Solid-Organ Transplant Recipients.
Er Dedekarginoglu B; Savas Bozbas S; Ulubay G; Oner Eyuboglu F; Haberal M
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):214-218. PubMed ID: 28260471
[TBL] [Abstract][Full Text] [Related]
31. Statin Use May Be Associated With a Lower Risk of Invasive Aspergillosis in Lung Transplant Recipients.
Villalobos AP; Foroutan F; Davoudi S; Kothari S; Martinu T; Singer LG; Keshavjee S; Husain S
Clin Infect Dis; 2023 Feb; 76(3):e1379-e1384. PubMed ID: 35900334
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology, clinical characteristics, and outcome of invasive aspergillosis in renal transplant patients.
Hoyo I; Sanclemente G; de la Bellacasa JP; Cofán F; Ricart MJ; Cardona M; Colmenero J; Fernández J; Escorsell A; Navasa M; Moreno A; Cervera C
Transpl Infect Dis; 2014 Dec; 16(6):951-7. PubMed ID: 25318640
[TBL] [Abstract][Full Text] [Related]
33. Associations between invasive aspergillosis and cytomegalovirus in lung transplant recipients: a nationwide cohort study.
Wulff SM; Perch M; Helweg-Larsen J; Bredahl P; Arendrup MC; Lundgren J; Helleberg M; Crone CG
APMIS; 2023 Nov; 131(11):574-583. PubMed ID: 37022293
[TBL] [Abstract][Full Text] [Related]
34. Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response.
Welte T; Len O; Muñoz P; Romani L; Lewis R; Perrella A
Infection; 2019 Dec; 47(6):919-927. PubMed ID: 31576498
[TBL] [Abstract][Full Text] [Related]
35. [Invasive aspergillosis in solid organ transplantation].
Silva JT; Torre-Cisneros J; Aguado JM
Rev Iberoam Micol; 2018; 35(4):206-209. PubMed ID: 30467000
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and outcome of systemic fungal infections in renal transplant recipients - A tertiary care experience.
Shekar M; Elumalai R; Elayaperumal I; Yelahanka RP; Anandkumar DG; Bandi VK; Matcha J
Saudi J Kidney Dis Transpl; 2019; 30(5):1137-1143. PubMed ID: 31696853
[TBL] [Abstract][Full Text] [Related]
37. Defining standards of CARE for invasive fungal diseases in solid organ transplant patients.
Garcia-Vidal C; Carratalà J; Lortholary O
J Antimicrob Chemother; 2019 Mar; 74(Suppl 2):ii16-ii20. PubMed ID: 31222312
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with mortality in transplant patients with invasive aspergillosis.
Baddley JW; Andes DR; Marr KA; Kontoyiannis DP; Alexander BD; Kauffman CA; Oster RA; Anaissie EJ; Walsh TJ; Schuster MG; Wingard JR; Patterson TF; Ito JI; Williams OD; Chiller T; Pappas PG
Clin Infect Dis; 2010 Jun; 50(12):1559-67. PubMed ID: 20450350
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
[TBL] [Abstract][Full Text] [Related]
40. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
